Fuc-GM1 is a tumor-associated antigen that is expressed in a large percentage of human small cell lung cancer (SCLC) tumors, making it a promising target in immuno-oncology.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
